search
Back to results

Tension Band Versus Locking Plate Fixation for the Treatment of Patella Fractures (TENPLA)

Primary Purpose

Patella Fracture, Surgery, Orthopedic Disorder

Status
Recruiting
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Tension band fixation
Plate fixation
Sponsored by
Rasmus Elsøe
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Patella Fracture focused on measuring patella fracture, surgery, Tension band, Plate

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Above 18 years of age
  • Patella fracture suitable for surgically treatment, with both surgical methods
  • AO classification 34-B, 34-C

Exclusion Criteria:

  • Open patella fracture above Gustillo grade 2
  • Bilateral patella fracture
  • Total knee replacement in the affected extremity
  • Other fractures of the affected extremity within the previous 12 months.
  • Other reasons for exclusion (unable to understand Danish, mentally unable to participate, etc).
  • Prior ipsilateral patella fracture

Sites / Locations

  • Aalborg University HospitalRecruiting
  • Aarhus University HospitalRecruiting
  • Regional Hospital HjoerringRecruiting
  • Regional Hospital KoldingRecruiting
  • Regional Hospital RandersRecruiting
  • Regional Hospital ViborgRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Tension band fixation

Plate fixation

Arm Description

Surgical fixation of the patella fracture utilizing the AO principles using K-wires, screws, cerclage and sutures by surgeons choice.

Surgical fixation of the patella fracture utilizing the AO principles and a locking plate with the number of screws by surgeons choice. Additional fixation by surgeons choice.

Outcomes

Primary Outcome Measures

Knee Injury and Osteoarthritis Outcome Score - (KOOS5)
The Knee Injury and Osteoarthritis Outcome Score (KOOS) 29 is a standardised patient-reported questionnaire developed to evaluate knee problems. The questionnaire includes five subscales: pain, ADL, symptoms, sport and QOL and an overall score KOOS5 can be calculated. A total score of 100 indicates no symptoms, and 0 indicates major symptoms.

Secondary Outcome Measures

Knee Injury and Osteoarthritis Outcome Score - (KOOS5)
The Knee Injury and Osteoarthritis Outcome Score (KOOS) 29 is a standardised patient-reported questionnaire developed to evaluate knee problems. The questionnaire includes five subscales: pain, ADL, symptoms, sport and QOL and an overall score KOOS5 can be calculated. A total score of 100 indicates no symptoms, and 0 indicates major symptoms.
Knee Injury and Osteoarthritis Outcome Score - subscales: pain, ADL, symptoms, sport and QOL.
The Knee Injury and Osteoarthritis Outcome Score (KOOS) 29 is a standardised patient-reported questionnaire developed to evaluate knee problems. The questionnaire includes five subscales: pain, ADL, symptoms, sport and QOL and an overall score KOOS5 can be calculated. A total score of 100 indicates no symptoms, and 0 indicates major symptoms.
EQ-5D-5L questionnaire (5-level version)
General health will be assessed using EQ-5D-5L questionnaire (5-level version), both the descriptive index and the EQ-VAS. It consists of five dimensions: Mobility, self-care, usual activities, pain/discomfort and anxiety/depression, and a self-rated health scale on a 20 cm vertical, visual analogue scale with endpoints labelled 'the best health you can imagine' and 'the worst health you can imagine'. An Eq5d-5L index of 1.0 indicated full health, 0 death, and -0.59 denoted a condition worse than death.
Pain intensity measured on a 10 cm VAS scale
Development in pain will be recorded by patient-reported pain intensity measured on a 10 cm visual analogue scale (VAS) with endpoints "no pain" and "maximal pain" for the worst pain during the last 24 hours and resting pain.
"PainDETECT" questionnaire
Knee pain and neuropathic pain will be assessed using the "PainDETECT" questionnaire. The "PainDETECT" screening questionnaire uses a scoring method between 1-38. A total score of 1 indicates no symptoms, and 38 indicates major symptoms.
Bone union
Bone union, will be evaluated on standard AP and side X-rays of the fractured patella. The evaluation of bone union will be defined as: i) visible callus formation, diminished no visible fracture line and no pain from the fracture site at weight-bearing and at clinical examination.
Maximum isometric knee-extension strength
Maximum isometric knee-extension strength at 60 degrees knee flexion measured as Nm/kg body mass. Will be measured bilaterally by a strap-mounted dynamometer attached to the wall (Mecmesin AFG2500, Mecmesin Ltd, West Sussex, UK)
Maximum isometric knee-flexion strength
Maximum isometric knee-flexion strength at 90 degrees knee flexion measured as Nm/kg body mass. Will be measured bilaterally by a strap-mounted dynamometer attached to the wall (Mecmesin AFG2500, Mecmesin Ltd, West Sussex, UK)
Knee range of motion
Knee range of motion. With the patient supine on an examination table the full range of passive motion in both knee joints will be measured using a standard goniometer.
Time to return to work
Measure the time from surgery to end of sick leave measured in days

Full Information

First Posted
May 13, 2021
Last Updated
December 10, 2021
Sponsor
Rasmus Elsøe
Collaborators
Aarhus University Hospital, Randers Regional Hospital, Regional Hospital Hjoerring, Regional Hospital Kolding, Viborg Regional Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04891549
Brief Title
Tension Band Versus Locking Plate Fixation for the Treatment of Patella Fractures
Acronym
TENPLA
Official Title
TENSION BAND VERSUS LOCKING PLATE FIXATION FOR THE TREATMENT OF PATELLA FRACTURE - a High Quality, Multicenter, Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
December 2021
Overall Recruitment Status
Recruiting
Study Start Date
September 1, 2021 (Actual)
Primary Completion Date
September 1, 2023 (Anticipated)
Study Completion Date
September 1, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Rasmus Elsøe
Collaborators
Aarhus University Hospital, Randers Regional Hospital, Regional Hospital Hjoerring, Regional Hospital Kolding, Viborg Regional Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study is a multicenter pragmatic, prospective, assessor-blinded, randomized independent clinical trial in which we compare locking plate fixation to standard tension band fixation in patients with patella fractures.
Detailed Description
This study is a multicenter pragmatic, prospective, assessor-blinded, randomized independent clinical trial in which we compare locking plate fixation to standard tension band fixation in patients with patella fractures. Primary objective The overall objective of the study is to compare the 1-year patient-reported Knee Injury and Osteoarthritis Outcome Score (KOOS5) after standard tension band fixation with locking plat fixation for patients with patella fractures. Secondary objectives Several other analyses are of interest and are planned but are not objectives of this study. Therefore, these analyses will, for the major part, hypothesis-generating. Analyses of this type include, but are not limited to harms, muscle atrophy, pain, general health, gait function, time to return to work and economical consequences between the two groups.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Patella Fracture, Surgery, Orthopedic Disorder
Keywords
patella fracture, surgery, Tension band, Plate

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This study is a multicenter pragmatic, prospective, assessor-blinded, randomized independent clinical trial
Masking
ParticipantCare ProviderOutcomes Assessor
Masking Description
Due to the surgical nature of the study the surgeon can not be blinded. The outcome assessor, patients and care providers will be blinded with regards to the two treatment groups.
Allocation
Randomized
Enrollment
122 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Tension band fixation
Arm Type
Active Comparator
Arm Description
Surgical fixation of the patella fracture utilizing the AO principles using K-wires, screws, cerclage and sutures by surgeons choice.
Arm Title
Plate fixation
Arm Type
Experimental
Arm Description
Surgical fixation of the patella fracture utilizing the AO principles and a locking plate with the number of screws by surgeons choice. Additional fixation by surgeons choice.
Intervention Type
Procedure
Intervention Name(s)
Tension band fixation
Intervention Description
Fracture fixation of the patella fracture with tension band.
Intervention Type
Procedure
Intervention Name(s)
Plate fixation
Intervention Description
Fracture fixation of the patella fracture with a plate.
Primary Outcome Measure Information:
Title
Knee Injury and Osteoarthritis Outcome Score - (KOOS5)
Description
The Knee Injury and Osteoarthritis Outcome Score (KOOS) 29 is a standardised patient-reported questionnaire developed to evaluate knee problems. The questionnaire includes five subscales: pain, ADL, symptoms, sport and QOL and an overall score KOOS5 can be calculated. A total score of 100 indicates no symptoms, and 0 indicates major symptoms.
Time Frame
One year following treatment
Secondary Outcome Measure Information:
Title
Knee Injury and Osteoarthritis Outcome Score - (KOOS5)
Description
The Knee Injury and Osteoarthritis Outcome Score (KOOS) 29 is a standardised patient-reported questionnaire developed to evaluate knee problems. The questionnaire includes five subscales: pain, ADL, symptoms, sport and QOL and an overall score KOOS5 can be calculated. A total score of 100 indicates no symptoms, and 0 indicates major symptoms.
Time Frame
3- and 6 months
Title
Knee Injury and Osteoarthritis Outcome Score - subscales: pain, ADL, symptoms, sport and QOL.
Description
The Knee Injury and Osteoarthritis Outcome Score (KOOS) 29 is a standardised patient-reported questionnaire developed to evaluate knee problems. The questionnaire includes five subscales: pain, ADL, symptoms, sport and QOL and an overall score KOOS5 can be calculated. A total score of 100 indicates no symptoms, and 0 indicates major symptoms.
Time Frame
3-, 6- and 12-months
Title
EQ-5D-5L questionnaire (5-level version)
Description
General health will be assessed using EQ-5D-5L questionnaire (5-level version), both the descriptive index and the EQ-VAS. It consists of five dimensions: Mobility, self-care, usual activities, pain/discomfort and anxiety/depression, and a self-rated health scale on a 20 cm vertical, visual analogue scale with endpoints labelled 'the best health you can imagine' and 'the worst health you can imagine'. An Eq5d-5L index of 1.0 indicated full health, 0 death, and -0.59 denoted a condition worse than death.
Time Frame
3-, 6- and 12-months
Title
Pain intensity measured on a 10 cm VAS scale
Description
Development in pain will be recorded by patient-reported pain intensity measured on a 10 cm visual analogue scale (VAS) with endpoints "no pain" and "maximal pain" for the worst pain during the last 24 hours and resting pain.
Time Frame
3-, 6- and 12-months
Title
"PainDETECT" questionnaire
Description
Knee pain and neuropathic pain will be assessed using the "PainDETECT" questionnaire. The "PainDETECT" screening questionnaire uses a scoring method between 1-38. A total score of 1 indicates no symptoms, and 38 indicates major symptoms.
Time Frame
3-, 6- and 12-months
Title
Bone union
Description
Bone union, will be evaluated on standard AP and side X-rays of the fractured patella. The evaluation of bone union will be defined as: i) visible callus formation, diminished no visible fracture line and no pain from the fracture site at weight-bearing and at clinical examination.
Time Frame
3-, 6- and 12-months
Title
Maximum isometric knee-extension strength
Description
Maximum isometric knee-extension strength at 60 degrees knee flexion measured as Nm/kg body mass. Will be measured bilaterally by a strap-mounted dynamometer attached to the wall (Mecmesin AFG2500, Mecmesin Ltd, West Sussex, UK)
Time Frame
12-months
Title
Maximum isometric knee-flexion strength
Description
Maximum isometric knee-flexion strength at 90 degrees knee flexion measured as Nm/kg body mass. Will be measured bilaterally by a strap-mounted dynamometer attached to the wall (Mecmesin AFG2500, Mecmesin Ltd, West Sussex, UK)
Time Frame
12-months
Title
Knee range of motion
Description
Knee range of motion. With the patient supine on an examination table the full range of passive motion in both knee joints will be measured using a standard goniometer.
Time Frame
3-, 6- and 12-months
Title
Time to return to work
Description
Measure the time from surgery to end of sick leave measured in days
Time Frame
3-, 6- and 12-months
Other Pre-specified Outcome Measures:
Title
Harms
Description
Adverse events, defined as any negative or unwanted reactions to the two groups will be recorded. Based on previous reports we will focus on: infection, DVT and re-operation. Patients are continuously requested to report any suspicion of a potential AE. Furthermore, adverse events (AE) will be recorded at 3-, 6- and 12-months follow-up by asking patients about potential AEs using open-probe questioning to ensure that all AEs are recorded. Furthermore, medical records will be checked at the primary endpoint (12 months) for all AEs occurring from inclusion until the 12 months follow-up. An AE is defined as any undesirable experience during follow-up leading to contact with the healthcare system (general practitioner or hospital). If an AE result in hospitalization, prolonged inpatient hospital care, result in re-surgery, or if an AE is life-threatening, result in death, permanent disability or damage, they will be categorized as serious adverse events (SAEs).
Time Frame
3-, 6- and 12-months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Above 18 years of age Patella fracture suitable for surgically treatment, with both surgical methods AO classification 34-B, 34-C Exclusion Criteria: Open patella fracture above Gustillo grade 2 Bilateral patella fracture Total knee replacement in the affected extremity Other fractures of the affected extremity within the previous 12 months. Other reasons for exclusion (unable to understand Danish, mentally unable to participate, etc). Prior ipsilateral patella fracture
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Rasmus Elsoe, MD, PhD
Phone
+4597660000
Email
rae@rn.dk
First Name & Middle Initial & Last Name or Official Title & Degree
Peter Larsen, PT, PhD
Phone
+4597660000
Email
peter.larsen@rn.dk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rasmus Elsoe, MD, PhD
Organizational Affiliation
Aalborg University Hospital, Denmark
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Peter Larsen, PT, PhD
Organizational Affiliation
Aalborg University Hospital, Denmark
Official's Role
Principal Investigator
Facility Information:
Facility Name
Aalborg University Hospital
City
Aalborg
ZIP/Postal Code
9000
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rasmus Joergensen, MD
Phone
+45 97 66 00 00
Email
rasjo@rn.dk
Facility Name
Aarhus University Hospital
City
Aarhus
ZIP/Postal Code
8200
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jeppe Barckman, MD, PhD
Phone
+457845 0000
Email
jeppbarc@rm.dk
Facility Name
Regional Hospital Hjoerring
City
Hjørring
ZIP/Postal Code
9800
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Predrag Kokanovic, MD
Phone
+4597640621
Email
p.kokanovic@rn.dk
Facility Name
Regional Hospital Kolding
City
Kolding
ZIP/Postal Code
6000
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Peter I Andersen, MD, PhD
Phone
+4576362000
Email
peter.ivan.andersen@rsyd.dk
Facility Name
Regional Hospital Randers
City
Randers
ZIP/Postal Code
8930
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rikke Thorninger, MD
Phone
+4578420000
Email
rikkthor@rm.dk
Facility Name
Regional Hospital Viborg
City
Viborg
ZIP/Postal Code
8800
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Steffen S Jensen, MD
Phone
+4578440000
Email
steffen.skov@viborg.rm.dk

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
A detailed statistical analysis plan will be made publicly available before the last patient is included in the study.
Links:
URL
https://vbn.aau.dk/ws/portalfiles/portal/410910476/Protokol_patella_multicenter_final_version_16042021.pdf
Description
The full study protocol are published online before study start

Learn more about this trial

Tension Band Versus Locking Plate Fixation for the Treatment of Patella Fractures

We'll reach out to this number within 24 hrs